TIA

Current Controversies in TIA Evaluation

TIA is a brief neurologic deficit due to cerebral ischemia, with no permanent infarction. It affects over 200,000 U.S. patients per year and may precede 14% to 23% of strokes. Many have sought risk stratification tools to determine who may be appropriate for discharge with follow-up. This post evaluates the new ACEP guidelines for TIA and the controversies in the ED evaluation of TIA.

Current Controversies in TIA Evaluation Read More »

If possible, get the mri before giving steroids in patients who present with cis or ms relapse. Best sleep aid generics. Sponsor a tv talk show.